The 10th Annual Agi Hirshberg Symposium will be held in conjunction with the annual meeting of the American Pancreatic Association in Miami from October 30—November 2, 2013. The program will […]
Novel Molecular Targets of Metformin in Pancreatic Cancer Cells
Normal cells become cancerous through a set of steps that result in the continuous activity of signaling pathways that stimulate their multiplication and dissemination to other sites in the organism. […]
Hirshberg Foundation for Pancreatic Cancer Research Announces the 2012-2013 Seed Grant Award Recipients
Final Media Contact: Donald Wilson (310) 899-2900 [email protected] THE HIRSHBERG FOUNDATION FOR PANCREATIC CANCER RESEARCH ANNOUNCES THE 2012-2013 SEED GRANT AWARD RECIPIENTS LOS ANGELES, Calif., – (November 1, 2012) – […]
Hirshberg Researcher Receives New Grant for $10 Million!
We are pleased to announce that Guido Eibl, M.D., Principal Investigator and Scientific Director of the Ronald S. Hirshberg Translational Pancreatic Cancer Research Laboratory at the UCLA School of Medicine, […]
UCLA study pinpoints types of bacteria in saliva associated with pancreatic cancer
By Rachel Champeau October 13, 2011 UCLA RESEARCH ALERT FINDINGS: A UCLA study has found variations in the types of bacteria found in the saliva of patients with pancreatic […]
Metformin continues to prove viability
Type 2 diabetes increases and metformin reduces total, colorectal, liver and pancreatic cancer incidences in Taiwanese: a representative population prospective cohort study of 800,000 individuals Download PDF release Metformin pilot […]